Thalidomide’s Return: A dark shadow still lurks within the pharmaceutical industry

Thalidomide is a synthetic drug developed in 1954 by German pharmaceutical company, Chemie Grünenthal, for use as a sedative in the treatment of insomnia and anxiety. Because of its purported atoxic nature, the use of this “wonder drug” quickly became widespread all over Europe. It was initially used to treat conditions like colds, headaches, and … Continue reading Thalidomide’s Return: A dark shadow still lurks within the pharmaceutical industry